Amy M. Wood

Partner
Full contact info

With my focus on executive and equity compensation, I’ve been a part of some of Cooley’s most high-profile offerings.

Experience

BroadSoft Sells to Cisco for $1.9 Billion

February 2, 2018

Cooley advised BroadSoft, the technology innovator in cloud PBX, unified communications, team collaboration and contact center solutions for businesses and service providers, on its sale to worldwide technology leader Cisco.

Read more

Related contacts

Barbara Borden
Partner, San Diego
Kevin Mills
Senior Counsel, Washington DC
Rowook Park
Partner, San Diego
Jacqueline Grise
Partner, Washington DC
Darren DeStefano
Partner, Reston
Amy M. Wood
Partner, San Diego
Todd Gluth
Partner, San Diego
Megan Browdie
Partner, Washington DC
Michael Tollini
Partner, Washington DC
J.G. Harrington
Special Counsel, Washington DC
Randy Sabett
Special Counsel, Washington DC
Kimberly Nguyen
Special Counsel, Reston
MaryBeth Shreiner
Associate, Reston
Rebecca Ross
Special Counsel, Washington DC
Charles Haley
Partner, Palo Alto

Related Practices & Industries

Jazz Pharmaceuticals Acquires Celator for $1.5 Billion

May 31, 2016

Cooley advised Jazz Pharmaceuticals on its $1.5 billion acquisition of Celator. The transaction adds the orphan drug VYXEOS which aims to treat AML. Jazz Pharmaceuticals, a Cooley client since 2006, is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs.

Read more

Related contacts

Barbara Borden
Partner, San Diego
Marya Postner
Partner, Palo Alto
Todd Gluth
Partner, San Diego
Amy M. Wood
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Kevin King
Partner, Washington DC
Bonnie Weiss McLeod
Of Counsel, Washington DC
Michael Tollini
Partner, Washington DC
Mischi a Marca
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Matthew D. Silverman
Special Counsel, San Diego
Megan Arthur Schilling
Partner, San Diego
Dani Nazemian
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington DC
Jonathan Rivinus
Partner, Colorado
Jonathan Rivinus
Partner, Colorado
John Paul Oleksiuk
Partner, New York
Edmond Lay
Associate, San Diego
Chadwick Mills
Partner, San Francisco
Jon Cousin
Associate, Washington DC

Related Practices & Industries

Xenon Pharmaceuticals Completes Initial Public Offering

November 21, 2014

Cooley advised the underwriters on Xenon Pharmaceuticals' initial public offering. Xenon is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications. Xenon has built a core-enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. The company now trades on the Nasdaq Global Market under the symbol "XENE."

Jefferies and Wells Fargo Securities acted as the joint book-running managers and Canaccord Genuity acted as co-manager for the offering.

Related contacts

Charlie Kim
Partner, San Diego
Drew Williamson
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Bill Christiansen
Partner, Seattle
Natasha Leskovsek
Of Counsel, Washington DC
Amy M. Wood
Partner, San Diego
Jonie Ing Kondracki
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Sale Kwon
Partner, Palo Alto
Megan Arthur Schilling
Partner, San Diego

Related Practices & Industries

NetScout Systems to Acquire Danaher Communications Business for $2.6B

October 16, 2014

Cooley is advising NetScout Systems on its definitive agreement to acquire the communications business of Danaher for $2.6 billion. According to The Wall Street Journal, the acquisition will create a global cybersecurity and IT management company.

NetScout is a market leading provider of performance analytics and operational intelligence solutions. Danaher is an industrial and health care technology company, whose communications businesses specialize in protecting and improving network performance through testing, monitoring and threat protection.

Related contacts

Miguel J. Vega
Partner, Boston
Barbara Borden
Partner, San Diego
Alfred Browne
Partner, Boston
Lesse Castleberry
Senior Counsel, New York
David Walsh
Partner, Reston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Jacqueline Grise
Partner, Washington DC
Mischi a Marca
Partner, San Francisco
Kevin King
Partner, Washington DC
Amy M. Wood
Partner, San Diego
Heather Harrington
Special Counsel, Boston
Michael Rohr
Partner, Boston
Richard Segal
Partner, New York
Rebecca Ross
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Christopher Kimball
Partner, Washington DC
Megan Browdie
Partner, Washington DC

Related Practices & Industries

Alder Biopharmaceuticals $80 Million Initial Public Offering

May 14, 2014

Seattle – Cooley advised Alder Biopharmaceuticals on its $80 million initial public offering. Alder is a Washington-based clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder is currently developing two lead product candidates: ALD403, an investigational monoclonal antibody for migraine, and Clazakizumab, an investigational monoclonal antibody for rheumatoid arthritis and other autoimmune indications, in collaboration with Bristol-Myers Squibb. The company now trades on the Nasdaq Global Stock Market under the symbol "ALDR."

Related contacts

Sonya Erickson
Partner and Business Department Chair, Seattle
John McKenna
Partner, Palo Alto
Julia Stark
Associate, Seattle
Alan Hambelton
Partner, Seattle
Yuri Weigel
Special Counsel, Seattle
Amy M. Wood
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Marya Postner
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto

Related Practices & Industries

View more

Rankings & accolades

The Legal 500 US: Leading Lawyer in Employee Benefits, Executive Compensation and Retirement (2023)

Memberships & affiliations

American Bar Association

National Association of Stock Plan Professionals

Society for Corporate Secretaries & Governance Professionals